FDA-Drug2023-11-08Class II
Liothyronine Sodium Tablets, USP, 5 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191,(U.T. of D & NH), India. NDC 62756-589-88
Hazard
Failed Impurities/Degradation Specifications.
Sold states
Nationwide within the United States
Affected count
7392 Bottles
Manufactured in
2 Independence Way, N/A, Princeton, NJ, United States
Products
Liothyronine Sodium Tablets, USP, 5 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191,(U.T. of D & NH), India. NDC 62756-589-88
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0083-2024More SUN PHARMACEUTICAL INDUSTRIES INC recalls
- FDA-Drug2026-06-17Sun Pharmaceutical budesonide inhalation suspension recalled for foreign particles
- FDA-Drug2026-06-17Sun Pharmaceutical doxorubicin injection recalled for glass particles
- FDA-Drug2026-04-22Taro Fluocinonide 0.05% Cream recalled for failed viscosity specifications
- FDA-Drug2026-04-22Taro Pharmaceuticals fluocinonide cream recalled for failed viscosity specifications
- FDA-Drug2026-04-22Taro Pharmaceuticals fluocinonide 0.05% cream recalled for viscosity defect
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief